S&P 5007,411.98▲0.1% Nasdaq24,975.82▼0.6% Dow51,947.25▲0.5% Russell 2K2,930.00▼0.3% 10-Yr4.68%−2bp VIX18.58−0.12 WTI$90.47▼1.9% Gold$4,055.70▲0.2% EUR/USD1.137▼0.3% BTC$64,671▼1.0% Nikkei66,423▲0.5%
At close · Fri, Jul 24, 2026
Daily Market Updates.

ETFs & Funds

Home›ETFs & Funds›ETFs›Niche ETFs gain as record inflows push targeted strate…

Niche ETFs gain as record inflows push targeted strategies

MarketBeat Ratings says record ETF inflows are benefiting niche funds focused on biotech trials, buy-now-pay-later, and disruptive medicine, with recent notable returns cited.

Reported · Written up by our desk · ETFs

Record inflows into exchange traded funds are supporting a range of niche strategies, according to MarketBeat Ratings.

The outlet highlights specific funds that are designed for targeted exposure, including BBC, LATR, and FMED.

MarketBeat Ratings links the performance to demand for specialized themes tied to biotech trials, buy-now-pay-later companies, and disruptive medicine.

← Newer storyStocks edge up as US-Iran hostilities pause lifts oil and sentiment

More like this

ETFs & FundsCME revives single-stock futures in the US
ETFs & FundsiShares U.S. Digital Infrastructure ETF shows signs of distribution
ETFs & FundsPINK vs. XLV: Two healthcare ETFs differ on fees and strategy
ETFs & FundsVanguard Financials ETF versus ProShares Ultra Financials for financial exposure
ETFs & FundsDimon says stock valuations are too high, points investors to ETFs

Sources

MarketBeat RatingsInnovative ETF Strategies That Are Paying Off This Summer

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.